Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
The University Of Manchester investment portfolio
The University Of Manchester has made numerous investments in companies such as Spotlight Pathology, Cytotrait, and Imperagen within the DeepTech sector.
university
Portfolio
28
Team
0
Portfolio (28)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Apini Therapeutics Limited Apini Therapeutics develops small‑molecule compounds for the treatment of chronic inflammatory diseases. Its programmes aim to deliver novel therapies that avoid inducing immune suppression. | Healthcare & Life Sciences | Huntingdon | Confirmed | 2025-11-25 |
| Cedyr Labs Limited | Industrials & Manufacturing | Ancoats | Confirmed | 2025-12-01 |
Shareholding changes (7)
The University Of Manchester's positions across portfolio companies2026
- ORDINARY £0.001 29,590 → 0
- ORDINARY 0 → 29,590
- ORDINARY 372,384 → 300,000
- A ORDINARY 0 → 72,384
Articles (3)
- 9 May 2026
- 28 Apr 2026
- 8 Apr 2026